Skip to main content
Clinical Trials/CTRI/2023/05/053042
CTRI/2023/05/053042
Not yet recruiting
Phase 3

Development and Evaluation of Pharmaceutical Care Intervention for Post COVID-19 Cardiovascular Patients

A0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I00-I99- Diseases of the circulatory system
Sponsor
A
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with cardiovascular disease after recovered from COVID\-19

Exclusion Criteria

  • 1\. Patients having cardiovascular disease before COVID\-19 exposure
  • 2\. Pregnant women and immunocompromised patients
  • 3\. Patients who are not willing to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials